ID: ALA3941150

Max Phase: Preclinical

Molecular Formula: C31H34F3N7O2

Molecular Weight: 593.65

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cnc(CN2CCC(c3ccn4nc(C(=O)N5CCN(Cc6ccc(C(F)(F)F)cc6)CC5)cc4c3)CC2)cn1

Standard InChI:  InChI=1S/C31H34F3N7O2/c1-43-29-19-35-26(18-36-29)21-38-9-6-23(7-10-38)24-8-11-41-27(16-24)17-28(37-41)30(42)40-14-12-39(13-15-40)20-22-2-4-25(5-3-22)31(32,33)34/h2-5,8,11,16-19,23H,6-7,9-10,12-15,20-21H2,1H3

Standard InChI Key:  ZNDKEFQVZIOPLS-UHFFFAOYSA-N

Associated Targets(Human)

AMP-activated protein kinase, alpha-2 subunit 1328 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PI3-kinase p110-alpha subunit 12269 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 593.65Molecular Weight (Monoisotopic): 593.2726AlogP: 4.49#Rotatable Bonds: 7
Polar Surface Area: 79.10Molecular Species: NEUTRALHBA: 8HBD: 0
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.55CX LogP: 3.93CX LogD: 3.53
Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.31Np Likeness Score: -1.51

References

1.  (2016)  Bicyclic nitrogen-containing aromatic heterocyclic amide compound, 

Source

Source(1):